via University of Turku
A research group at the University of Turku has led the development of a new method to evaluate vaccine safety. The new method may significantly reduce the use of animal testing in the vaccine industry.
Vaccines are safe and potent pharmaceutical products that prevent infectious diseases caused by viruses and bacteria, and reduce the spread of pathogens among the population. A vaccine prevents an infectious disease because the body develops an ability to recognise and destroy the pathogen. Vaccines are generally designed from a weakened pathogen, or parts of it. The vaccine industry uses effective methods to ensure vaccine safety, and constantly develops new methods as well.
The pertussis vaccine, which also belongs to the Finnish national vaccination programme, contains the surface structures of the pertussis bacteria and inactivated forms of the pertussis toxin produced by the bacteria. The pertussis toxin attaches to the surface of the cell, penetrates it, and destroys the vital control system of the cell.
The research group at the University of Turku has led the development of the new method that can be used to ensure the safety of the pertussis toxin in the pertussis vaccine. The new iGIST method (Interference in G?i-mediated Signal Transduction) detects how the pertussis toxin destroys the vital control system of the cell.
– Compared to the current methods in the vaccine industry, iGIST is more effective and enables the detection of up to 100 times lower levels of pertussis toxin. iGIST is entirely based on using laboratory grown, human-based cells. Therefore, it may significantly reduce the use of animal testing in the vaccine industry, says Dr Arto Pulliainen from the University of Turku who was the principal investigator of the research group that was in charge of developing the method.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Vaccine safety
- Not a booster: 4 notes on fall COVID vaccines
Previously, the CDC's Bridge Access Program offered free COVID-19 shots for adults who did not have an insurance plan that covered the vaccine, but the program ends in August. "This year we won't have ...
- COVID-19 vaccines for kids: What you need to know
Coronavirus disease 2019 (COVID-19) vaccines are available to children in the U.S. Here's what parents need to know about the safety and effectiveness of the vaccine, the possible side effects, and ...
- Vaccines tell a success story that Robert F. Kennedy Jr. and Trump forget – here are some key reminders
Vaccinations have provided significant protection for the public against infectious diseases. However, there was a modest decrease in support in 2023 nationwide for vaccine requirements for children ...
- Review of CDC COVID-19 Vaccine Safety Research and Communications (Meeting 2)
The National Academies of Sciences, Engineering, and Medicine are private, nonprofit institutions that provide expert advice on some of the most pressing challenges facing the nation and world. Our ...
- CDC ACIP Meeting: Updated Guidelines for RSV, COVID-19, HPV, and Other Vaccines
2 This decision was influenced by data from the CDC’s Immunization Safety Office and the FDA’s report on Vaccine Safety Datalink (VSD) Rapid Cycle Analyses (RCA) on the risk for Guillain Barré ...
Go deeper with Google Headlines on:
Vaccine safety
[google_news title=”” keyword=”vaccine safety” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Vaccine safety evaluation
- WHO launches initiative to develop mRNA vaccines against bird flu
The World Health Organization announced Monday that it has launched an initiative to help accelerate the development of a human bird flu vaccine using messenger RNA (mRNA) technology. The project, ...
- The right way to counter a poor Covaxin safety study
It took all of five days for the Indian Council of Medical Research (ICMR) to strongly criticise the poor design of the long-term safety study of Covaxin by researchers from the Banaras Hindu ...
- USDA-APHIS issues CVB notice
The U.S. Department of Agriculture-Animal Plant Health Inspection Service issued a CVB notice July 23, due to the number of highly pathogenic avian influenza cases in livestock herds.
- Ensuring Excellence in Medicine: A Closer Look at Quality Specifications
The World Health Organization's guidelines on quality specifications for medicines, vaccines, and in vitro diagnostics emphasize the importance of Quality Management Systems, Patient-Centric ...
- UK MHRA approves Pfizer/BioNTech’s Comirnaty JN.1 Covid-19 vaccine for adults and children from infancy
UK MHRA approves Pfizer/BioNTech’s Comirnaty JN.1 Covid-19 vaccine for adults and children from infancy: United Kingdom Friday, July 26, 2024, 09:00 Hrs [IST] The UK Medicines a ...
Go deeper with Google Headlines on:
Vaccine safety evaluation
[google_news title=”” keyword=”vaccine safety evaluation” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]